Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04857437 · ClinicalTrials.gov registry record · Phase 1
Study in Healthy Adults Evaluating PF-07202954
A Phase 1 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT04857437 is a Phase 1 study that has completed, run by Pfizer. The registered enrollment target is 12 participants.
The verdict
NCT04857437, a Phase 1 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
The study is planned as a 3 part design with investigator and participant blinded (sponsor-open), placebo controlled, randomized, dose escalation in Part 1 and Part 2; and a randomized, open label design, in Part 3 (if conducted).
Interventions
- DRUG Placebo
- DRUG PF-07202954 Repeat Dose
- DRUG PF-07202954 Single Dose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2021-05-13 |
| Est. Completion | 2021-09-17 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04857437
The ClinicalTrials.gov registry entry for NCT04857437 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT04857437 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04857437 about?
NCT04857437 is a clinical study titled "Study in Healthy Adults Evaluating PF-07202954". The study is planned as a 3 part design with investigator and participant blinded (sponsor-open), placebo controlled, randomized, dose escalation in Part 1 and Part 2; and a randomized, open label design, in Part 3 (if conducted).
What is the current status of trial NCT04857437?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2021-05-13. Estimated completion is 2021-09-17.
What interventions are being tested in trial NCT04857437?
The interventions under investigation include: Placebo (DRUG), PF-07202954 Repeat Dose (DRUG), PF-07202954 Single Dose (DRUG).
Who is sponsoring clinical trial NCT04857437?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.